Crossmark

Tolerability and safety of a new oral device for prevention and treatment of oral mucositis in patients with hematologic malignancies undergoing chemotherapy

Crossref DOI link: https://doi.org/10.1007/s00520-025-09722-0

Published Online: 2025-07-31

Published Print: 2025-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Oganesyan, Artem

Harutyunyan, Lusine

Vanoyan, Araksya

Martirosyan, Nare

Badikyan, Maria

Gregory, Mark

Oganesyan, Tigran

Ghahramanyan, Nerses

Ehrenpreis, Eli D.

Hakobyan, Yervand
Funding

Funding for this research was provided by:

E2Bio Life Sciences (2022002)
License Information

Text and Data Mining valid from 2025-07-31

Version of Record valid from 2025-07-31
More Information

Article History

Received: 26 July 2024

Accepted: 27 June 2025

First Online: 31 July 2025

Declarations

:

: Eli D Ehrenpreis MD is the inventor of Bocaliner and CEO of E2Bio Life Sciences, LLC, the company providing funding for this study.

Document is current

Any future updates will be listed below